Xiaoping Wu
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Mechanisms and Therapy
Papers in
-
- Liver Disease Diagnosis and Treatment 4
-
- Hepatocellular Carcinoma Treatment and Prognosis 1
- Co-authors
- Wei Wei (1 shared paper)Ming Jun Shi (1 shared paper)Ying Qiang Guo (1 shared paper)Qi-jiong Li (1 shared paper)Rong Guo (1 shared paper)Li Xu (1 shared paper)Minke He (1 shared paper)Ming Dan Zhao (1 shared paper)
In The Last Decade
Xiaoping Wu
25 papers receiving 802 citations
Xiaoping Wu's Hit Papers
Peers
Comparison fields: 5 of 77
- Hepatology 358
- Pathology and Forensic Medicine 80
- Epidemiology 129
- Nephrology 27
- Obstetrics and Gynecology 26
Countries citing papers authored by Xiaoping Wu
This map shows the geographic impact of Xiaoping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Wu more than expected).
Fields of papers citing papers by Xiaoping Wu
This network shows the impact of papers produced by Xiaoping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Wu. The network helps show where Xiaoping Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion Hit paper breakdown → | 2019 | 425 |
| 2 | 2017 | 87 | |
| 3 | 2019 | 52 | |
| 4 | 2010 | 48 | |
| 5 | 2022 | 36 | |
| 6 | 2013 | 27 | |
| 7 | 2014 | 26 | |
| 8 | 2017 | 19 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 13 | |
| 12 | 2022 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2016 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2019 | 3 | |
| 20 | [Clinical Research on Double-needle Winding and Pulling Combined with Electroacupuncture Therapy in Treating Scapulohumeral Periarthritis]. | 2017 | 2 |
About Xiaoping Wu
Xiaoping Wu is a scholar working on Epidemiology, Hepatology, Pharmacology, Oncology and Neurology, having authored 26 papers that have together received 811 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Diagnosis and treatment of tuberculosis (3 papers), COVID-19 Clinical Research Studies (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Cannabis and Cannabinoid Research (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper), Cholesterol and Lipid Metabolism (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Hepatology (358 citations), Pathology and Forensic Medicine (80 citations), Epidemiology (129 citations), Nephrology (27 citations) and Obstetrics and Gynecology (26 citations). Xiaoping Wu has collaborated with scholars based in China, Hong Kong and Israel. Frequent co-authors include Wei Wei, Ming Jun Shi, Ying Qiang Guo, Qi-jiong Li, Rong Guo, Li Xu, Minke He, Ming Dan Zhao, Zhongguo Zhou and Ruhai Zou. Their work appears in journals such as Lipids in Health and Disease, Frontiers in Medicine, Frontiers in Oncology, Information Sciences and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.